Wolfe Research Assumes West Pharmaceutical Servs at Outperform

Benzinga Newsdesk www.benzinga.com Negative 35.5%

Neg 35.5% Neu 0% Pos 0%

Wolfe Research analyst Mike Polark assumes West Pharmaceutical Servs (NYSE:WST) with a Outperform rating.

Comments

No comments yet. Be the first!